Title:
SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING DRY MACULAR DEGENERATION
Document Type and Number:
WIPO Patent Application WO/2023/120828
Kind Code:
A1
Abstract:
The present invention relates to superoxide dismutase and a use thereof for preventing or treating dry age-related macular degeneration. More specifically, the present invention relates to a pharmaceutical composition or a therapeutic method for prevention or treatment of dry macular degeneration. The composition and method according to the present invention can be effectively used to prevent or treat dry macular degeneration by reducing or preventing drusen formation and/or drusenoid lesions.
Inventors:
PAN JAE GU (KR)
KIM EUI JOONG (KR)
CHANG IN IK (KR)
KIM JEONG HYUN (KR)
KIM EUI JOONG (KR)
CHANG IN IK (KR)
KIM JEONG HYUN (KR)
Application Number:
PCT/KR2022/007001
Publication Date:
June 29, 2023
Filing Date:
May 16, 2022
Export Citation:
Assignee:
GENOFOCUS CO LTD (KR)
BIOMLOGIC INC (KR)
BIOMLOGIC INC (KR)
International Classes:
A61K38/16; A23K20/189; A23L33/195; A61P27/02; C12N9/02; C12N15/75
Foreign References:
US20210275645A1 | 2021-09-09 | |||
JP2012200168A | 2012-10-22 | |||
US7270991B2 | 2007-09-18 | |||
KR20040063943A | 2004-07-14 | |||
US20140335068A1 | 2014-11-13 |
Other References:
"GENOFOCUS CO., LTD. Quarterly Report", 17 May 2021, GENOFOCUS, South Korea, article ANONYMOUS: "GENOFOCUS CO., LTD. Quarterly Report", pages: 1 - 226, XP009547499
LEE HYEJOONG, DAESUNG SHIN: "Newswalker_Bio Industry Diagnosis⑥_Genofocus] Debts soared due to decrease in deficit accumulated capital", 29 November 2021 (2021-11-29), pages 1 - 9, XP093074080, Retrieved from the Internet [retrieved on 20230816]
LEE HYEJOONG, DAESUNG SHIN: "Newswalker_Bio Industry Diagnosis⑥_Genofocus] Debts soared due to decrease in deficit accumulated capital", 29 November 2021 (2021-11-29), pages 1 - 9, XP093074080, Retrieved from the Internet
Attorney, Agent or Firm:
SEUM IP (KR)
Download PDF: